The aim of the present review is to examine the cellular processes underlying the actions of these new, highly significant classes of peptide receptor agonists
These drugs work by mimicking the incretin hormone GLP-1, which reduces appetite, slows gastric emptying, and improves appetite suppression signaling in the brain
Regulatory status Retatrutide and similar peptides are investigational not approved by the FDA or any regulator
On one side, a study showed that body weight and whole-body fat mass decreased with both treatments, but without difference between the two arms [58]
This shift recognizes both the benefits of these medications and the importance of patient-specific decision making, These precautions may include a clear liquid diet for 24 hours before surgery or closer monitoring during anesthesia
Clear rules prevent guesswork when side effects appear